CARMN and neoplasm: The expression of CARMN from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) showed a significant downregulation in 16 out of 31 tumor type cohorts compared with corresponding normal tissues, especially for cervical squamous carcinoma (CESC) (Fig. S4).